Company
United StatesPublic company, NASDAQ: GILDGilead Sciences, Inc. (NASDAQ: GILD), La Verne, CA – FDA Inspections
Inspection records and compliance data for Gilead Sciences, Inc. in La Verne, California. 4 FDA inspections on record, 2 Form 483s, last inspected February 18, 2026. Publicly traded as NASDAQ: GILD.
Company Profile
This profile covers Gilead Sciences, Inc. based in La Verne, California, United States.
FDA Inspection History
- FDA inspections
- 4
- OAI
- 0
- VAI
- 3
- NAI
- 1
- Form 483s
- 2
- Warning letters
- 0
First inspected May 14, 2019. Last inspected February 18, 2026.
Most cited issue areas
- Procedures not in writing, fully followed2 inspections
- Annual visual exams of drug products1 inspection
- Buildings not maintained in good state of repair1 inspection
FDA inspections (4)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| February 18, 2026 | VAI | Human Drugs · Drug Quality Assurance | 1304734 |
| February 12, 2024 | VAI | Human Drugs · New Drug Evaluation | 1229435 |
| December 17, 2021 | VAI | Human Drugs · Drug Quality Assurance | 1159086 |
| May 14, 2019 | NAI | Human Drugs · Drug Quality Assurance | 1093610 |
FDA documents
People (5)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Gilead Sciences, Inc.
Stock ticker
GILD
Exchange
NASDAQ
Share price
$167.95
Market cap
$208.3B
Price as of
November 13, 2026
FEI Number
3013189568
Address
1800 Wheeler St, La Verne, California 91750, United States
Country
United States
ID: aef302cf-d6ca-423c-8e9a-4529b8be42ea